Athersys Inc. (Nasdaq: ATHX), a biopharmaceutical company focused on developing an innovative stem cell platform, similar to companies like Mesoblast (MSB: ASX), Osiris (Nasdaq: OSIR) and ThermoGenesis Corp (Nasdaq: KOOL), recently announced that its CEO would deliver the keynote address at the World Stem Cell Summit 2011.
Recent Posts
- New CRISPR tool enables more seamless gene editing — and improved disease modeling
- Building a regenerative medicine industry: Lessons from North Carolina
- Healthspan Action Coalition and Kitalys Institute Propose Landmark Legislation to Promote Healthy Longevity
- Probing the Mysteries of the Aging Brain
- Cells That Build Themselves Into an Embryo? Scientists Just Made It Happen
- Will Stem Cell Clinics Flourish Under RFK Jr.?